4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-046424
Chief Business Officer sold 18,000 shares at $9.25 ($166,500)
- Chief Business Officer acquired 18,000 shares (option exercise)
- Chief Business Officer gave up 3,603 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Virani Shafique · Chief Business Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-15 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −3,603 | $9.19 | $33,112 | 140,351 | D |
| 2023-08-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +18,000 | $2.22 | $39,960 | 158,351 | D |
| 2023-08-15 | Sale : show line 3 in the form 10b5-1 | −18,000 | $9.25 | $166,500 | 140,351 | D |
| Open-market sales · 18,000 sh · avg $9.25 · $166,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −18,000 | $2.22 | 2030-03-03 | 18,000 | 451,469 | D |
Loading xslF345X05/doc4.xml…